KNOW ESR1 logo

Metastatic Breast Cancer (mBC) Patient Educational Events

ESR1  Mutations in mBC: Should I Get Tested?

Nearly 1 out of 2 people living with ER+/HER2- mBC may develop an ESR1  mutation after progression on hormone therapy.

Engage with a community of individuals like you where you’ll learn about how your mBC may change over time. You’ll also hear about the importance of testing for the ESR1  mutation from a metastatic breast cancer expert, and a real patient/caregiver story.

NEXT EVENT: [Date]

Thanks!

hero divider chevron

*Speakers are paid consultants by Stemline Therapeutics, Inc.

Back

*Indicates a required field

If yes to text: Message and data rates may apply, you can opt out of texts by replying STOP to the messages or calling 1-855-261-7434

If your parent or another adult is interested in attending this event, they need to call to register. People under 18 years old may not register for this event.

Register
Form processing animation

There was a problem

Please check your information and try again

Return to form